We are live on ! Find out more
CC

Chicago Capital Portfolio holdings

AUM $4.15B
1-Year Est. Return 31.09%
This Fund
S&P 500
This Quarter Est. Return
+26.89%
1 Year Est. Return
+31.09%
3 Year Est. Return
+117.08%
5 Year Est. Return
+137.61%
10 Year Est. Return
AUM
$4.15B
AUM Growth
+$444M
Cap. Flow
-$116M
Cap. Flow %
-2.78%
Top 10 Hldgs %
37.68%
Holding
379
New
24
Increased
112
Reduced
140
Closed
18

Top Buys

Rank Stock Value
1
CVNA icon
Carvana
CVNA
+$40.2M
2
RVMD icon
Revolution Medicines
RVMD
+$36.8M
3
STX icon
Seagate
STX
+$14.6M
4
FICO icon
Fair Isaac
FICO
+$11.7M
5
DXCM icon
DexCom
DXCM
+$8.62M

Top Sells

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$51.9M
2
INTU icon
Intuit
INTU
+$45.3M
3
VRT icon
Vertiv
VRT
+$21.6M
4
CSGP icon
CoStar Group
CSGP
+$18.2M
5
MSFT icon
Microsoft
MSFT
+$17.5M

Sector Composition

Rank Sector Weight
1 Technology 31.69%
2 Healthcare 17.3%
3 Industrials 12.28%
4 Financials 11.46%
5 Communication Services 11.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INTU icon
51
Intuit
INTU
$86.5B
$13.7M 0.33%
52,673
-130,154
-71% -$45.3M
ORCL icon
52
Oracle
ORCL
$374B
$13.5M 0.33%
92,133
+1,417
+2% +$257K
FAST icon
53
Fastenal
FAST
$54.7B
$13.3M 0.32%
276,342
-399
-0.1% -$18.1K
MU icon
54
Micron Technology
MU
$930B
$13.1M 0.32%
11,378
+2,175
+24% +$1.63M
VICR icon
55
Vicor
VICR
$9.56B
$12.8M 0.31%
33,812
+13,090
+63% +$3.57M
CLS icon
56
Celestica
CLS
$38.1B
$11.4M 0.27%
31,266
+3,026
+11% +$1.14M
INTC icon
57
Intel
INTC
$455B
$10.7M 0.26%
76,796
+2,724
+4% +$275K
CAT icon
58
Caterpillar
CAT
$375B
$10.7M 0.26%
10,003
+2,110
+27% +$1.85M
TMO icon
59
Thermo Fisher Scientific
TMO
$213B
$10.3M 0.25%
20,642
-12,015
-37% -$5.77M
ISRG icon
60
Intuitive Surgical
ISRG
$127B
$10.3M 0.25%
25,955
-9,520
-27% -$4.16M
ARM icon
61
Arm
ARM
$256B
$10.2M 0.24%
28,679
+252
+0.9% +$67K
TER icon
62
Teradyne
TER
$57.6B
$10.1M 0.24%
20,937
+862
+4% +$325K
ABBV icon
63
AbbVie
ABBV
$443B
$10.1M 0.24%
40,087
-2,939
-7% -$632K
AXON
64
Axon Enterprise
AXON
$42.5B
$9.9M 0.24%
17,657
-1,660
-9% -$695K
MORN icon
65
Morningstar
MORN
$7.22B
$9.51M 0.23%
60,972
-13,190
-18% -$2.29M
CCJ icon
66
Cameco
CCJ
$37.6B
$9.17M 0.22%
90,058
+2,875
+3% +$322K
IRM icon
67
Iron Mountain
IRM
$36.4B
$8.83M 0.21%
69,881
-14,070
-17% -$1.72M
GLW icon
68
Corning
GLW
$119B
$8.81M 0.21%
34,482
+1,273
+4% +$232K
ZBRA icon
69
Zebra Technologies
ZBRA
$14B
$8.57M 0.21%
32,551
-1
-0% -$235
VTI icon
70
Vanguard Morningstar Total Stock Market ETF
VTI
$660B
$8.57M 0.21%
23,149
-14,522
-39% -$5.19M
VRTX icon
71
Vertex Pharmaceuticals
VRTX
$121B
$8.46M 0.2%
17,029
+4,910
+41% +$2.18M
SPOT icon
72
Spotify
SPOT
$103B
$7.87M 0.19%
17,133
-4,501
-21% -$2.15M
RTX icon
73
RTX Corp
RTX
$290B
$7.79M 0.19%
41,071
+581
+1% +$107K
TSLA icon
74
Tesla
TSLA
$1.23T
$7.71M 0.19%
18,329
+1,020
+6% +$406K
IBM icon
75
IBM
IBM
$211B
$7.71M 0.19%
27,410
+3,125
+13% +$787K

Similar funds

Chicago Capital's Q2 2026 Portfolio in Review

As of Q2 2026, Chicago Capital held 379 positions worth $4.15B, up 12% from $3.71B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Chicago Capital's Q2 2026 filing shows 24 new, 112 increased, 140 reduced and 18 closed positions. Its largest new stake was Revolution Medicines: 251,847 shares worth $47.2M. The largest sale was ExxonMobil, an estimated $51.9M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 29% a quarter earlier, followed by Healthcare and Industrials.

  • Chicago Capital's largest Q2 2026 buy was Revolution Medicines: 251,847 shares worth $47.2M.
  • Chicago Capital added most to Carvana in Q2 2026, an estimated $40.2M increase.
  • Chicago Capital's biggest Q2 2026 reduction was Intuit, cutting an estimated $45.3M.
  • Chicago Capital fully exited ExxonMobil in Q2 2026, selling an estimated $51.9M.
  • Chicago Capital's ten largest holdings make up 38% of its $4.15B portfolio in Q2 2026.
  • Chicago Capital opened 24 new positions and closed 18 in Q2 2026.
  • Chicago Capital's portfolio value rose 12% quarter-over-quarter to $4.15B.

Based on Chicago Capital's 13F filing for Q2 2026, filed 28 Jul 2026.